TLR4 and infection: The AS04TM adjuvant system, containing an endotoxin-derived TLR4 agonist, MPL, along with aluminum salt, is currently formulated in marketed vaccines such as Fendrix® and Cervarix® approved for the prevention of infections by pneumococcal bacteria and human papillomavirus, respectively [24].